Method of measuring pyrophosphate

• US 8,105,766 B2
• Filed: 02/27/2009
• Issued: 01/31/2012
• Est. Priority Date: 02/28/2008
• Status: Active Grant

• Current Assignee: Asahi Kasei Pharma Corporation (Asahi Kasei Corporation), Ichibiki Co., Ltd.
• Original Assignee: Asahi Kasei Pharma Corporation (Asahi Kasei Corporation), Ichibiki Co., Ltd.
• Inventors: Ikura, Yoshiaki, Nishimura, Atsuhisa, Sakasegawa, Shinichi, Kumazawa, Toshihiko, Imamura, Shigeyuki
• Primary Examiner(s): Whisenant, Ethan C
• Application Number:
  US12/395,438
• Publication Number:
  US 20090246783A1
• Time in Patent Office: 1,068 Days
• Field of Search: 435/4, 435/15, 435/6.1, 530/350
• US Class Current: 435/4
• CPC Class Codes: C12Q 1/48 involving transferase
• CPC Class Codes: C12Q 1/485 involving kinase

Abstract

Provided is a novel and useful method of measuring pyrophosphate in a sample. There may be provided a novel and useful method of measuring pyrophosphate in a sample using pyruvate orthophosphate dikinase, nicotinamide-nucleotide adenylyltransferase, and dehydrogenase.

Claims

1. A method of determining the concentration of pyrophosphate in a sample, which method comprises the following steps

(1) a step comprising a first reaction for producing ATP by contacting pyrophosphate which may be present in the sample with pyruvate orthophosphate dikinase in the presence of at least AMP;

(2) a step comprising a second reaction for producing pyrophosphate and NAD by contacting the ATP produced in the first reaction with nicotinamide-nucleotide adenylyltransferase;

(3) a step comprising a third reaction for reducing the NAD produced by the second reaction into NADH;

(4) a step comprising detecting the amount of NADH produced by the third reaction; and

(5) determining the concentration of pyrophosphate in the sample based on the amount of NADH produced in the above step.

2. The method of selectively measuring pyrophosphate in a sample according to claim 1, wherein step (4) further comprises:

converting the NADHs produced by the third reaction into a reduced nitroblue tetrazolium salt and NADs in a fourth reaction in the presence of a nitroblue tetrazolium salt; and

detecting the reduced nitroblue tetrazolium salt produced by the fourth reaction.

3. The method of selectively measuring pyrophosphate in a sample according to claim 2, wherein the NADs produced by the fourth reaction is used in the third reaction to perform a cycling reaction between the third reaction and the fourth reaction.

4. The method of selectively measuring pyrophosphate in a sample according to any one of claims 1 to 3, wherein the pyrophosphate produced by the second reaction is used in the first reaction to perform a cycling reaction between the first reaction and the second reaction.

5. The method of selectively measuring pyrophosphate in a sample according to claim 1, wherein the sample contains triphosphorylated deoxyribonucleic acids (dNTPs).

6. The method of selectively measuring pyrophosphate in a sample according to claim 1, wherein the nicotinamide-nucleotide adenylyltransferase is any of the following enzymes [1] to [3]:

[1] an enzyme which has an amino acid sequence of SEQ ID NO;

6 and may catalyze the second reaction;

[2] an enzyme which has the amino acid sequence of SEQ ID NO;

6 with deletion, substitution, or addition of one or several amino acids and may catalyze the second reaction; and

[3] an enzyme which has a substrate specificity ratio for dNTPs and ATP (substrate specificity for dNTPs/substrate specificity for ATP) of 5% or less and may catalyze the second reaction.

7. A method of detecting or quantifying a nucleic acid, comprising measuring, by the method according to claim 1, pyrophosphate in a sample subjected to nucleic acid amplification or a sample prepared from the sample.

8. A method for detecting or quantifying a nucleic acid, said method comprising measuring, by the method according to claim 1, pyrophosphate in a sample subjected to nucleic acid amplification or a sample prepared from the sample by using a composition comprising at least the following components (1) to (7):

(1) a metal ion;

(2) AMP;

(3) phosphoenolpyruvate;

(4) pyruvate orthophosphate dikinase;

(5) β

-nicotinamide mononucleotides;

(6) nicotinamide-nucleotide adenylyltransferase; and

(7) a reduced NAD substance.

9. A method for detecting or quantifying a nucleic acid, said method comprising measuring by the method according to claim 1, pyrophosphate in a sample subjected to nucleic acid amplification or a sample prepared from the sample by using a composition comprising the following two reagents (A) and (B):

(A) a first reagent containing at least the following components (1) to (4);

(1) a metal ion;

(2) AMP;

(3) phosphoenolpyruvate; and

(4) pyruvate orthophosphate dikinase;

(B) a second reagent containing at least the following components (5) to (7);

(5) β

-nicotinamide mononucleotides;

(6) nicotinamide-nucleotide adenylyltransferase; and

(7) a reduced NAD substance.

10. The method according to claim 1, wherein the sample is a biological fluid.

11. The method according to claim 10, wherein the biological fluid is selected from the group consisting of synovial fluid, whole blood, plasma, serum, hemocyte, spinal fluid, lymph, urine and extracts thereof.

12. The method according to claim 1, wherein the sample is selected from the group consisting of seawater, natural water, fruit juice, and waste fluid.

13. The method according to claim 1, wherein the pyruvate orthophosphate dikinase is obtained from Thermotoga maritima.

14. The method according to claim 1, wherein the nicotinamide-nucleotide adenylyltransferase is obtained from yeast.

15. The method according to claim 6, wherein the nicotinamide-nucleotide adenylyltransferase comprises SEQ ID NO:

6.

16. The method according to claim 6, wherein the nicotinamide-nucleotide adenylyltransferase comprises an enzyme comprising a substrate specificity ratio for dNTPs and ATP (substrate specificity for dNTPs/substrate specificity for ATP) of 5% or less.

17. The method according to claim 8, wherein the metal ion is magnesium.

18. The method according to claim 1, wherein in step (5) the amount of NADH produced in step (4) is compared with a reference value.

19. The method according to claim 1, wherein step (5) further comprises

determining the concentration of pyrophosphate in the sample by comparing the amount of NADH determined in step (4) with an amount of NADH obtained by steps (1)-(4) from a control sample comprising a known concentration of pyrophosphate, thereby selectively measuring pyrophosphate in the sample.